In a prior study, LRP protected against ventricular arrhythmia caused by total ischemia and reperfusion, and it ultimately reduced the incidence of sudden cardiac death by suppressing JNK activation and restoring Cx43 expression (Yan et al., 2021). The gene discussed is GJA1; the disease is Ventricular arrhythmia.